Search results for "BODIES"

showing 10 items of 2217 documents

Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: A regression analysis of i…

1991

Abstract To evaluate whether clinical and laboratory features of a hepatitis B surface antigen (HBsAg) carrier can predict risks of infection, its chronicity, and the development of liver disease among close contacts, the authors studied a cohort of 994 first degree relatives or cohabitants (household contacts) of 226 non-drug-addicted chronic HBsAg carriers (index cases), of whom 77% had liver disease and 26% were superinfected by hepatitis D virus (HDV). A logistic form of regression analysis was used to assess the role of each feature in the index case as predictor of hepatitis B virus (HBV)- and HDV-related outcomes among household contacts. Six models of risk, expressed as odds ratios,…

AdultMaleRiskHepatitis B virusHBsAgAdolescentEpidemiologymedicine.disease_causeLiver diseaseHumansMedicineHepatitis AntibodiesChildIndex caseAgedFamily HealthHepatitis B virusHepatitis B Surface Antigensbusiness.industryHepatobiliary diseaseInfantvirus diseasesMiddle AgedHepatitis BHepatitis Bmedicine.diseaseHepatitis Ddigestive system diseasesItalyHBeAgChild PreschoolCarrier StateDNA ViralMutationImmunologyRegression AnalysisFemaleHepatitis D virusHepatitis Delta Virusbusiness
researchProduct

Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metast…

2011

Abstract Background We have extensively assessed a biweekly regimen of irinotecan plus folinic acid and fluorouracil bolus (IRIFAFU) in metastatic colorectal cancer (MCRC). Here, we report on the safety and activity of BIFF (bevacizumab plus IRIFAFU) regimen in 94 mCRC patients. Patients and Methods Bevacizumab 5 mg/kg (1 hour), and irinotecan 180 mg/m 2 (1hour) were given intravenously on day 1, 6S-folinic acid 250 mg/m 2 (2 hours), and fluorouracil 850 mg/m 2 (bolus) were given intravenously on day 2 every 2 weeks for a median of 9 cycles per patient (range, 1-12), and maintenance bevacizumab alone was delivered in 16 cases. Results Grade ≥ 3 hematologic toxicities were neutropenia (50%) …

AdultMaleRiskOncologyAntimetabolites Antineoplasticmedicine.medical_specialtyBevacizumabLeucovorinAngiogenesis InhibitorsAntibodies Monoclonal HumanizedIrinotecanFolinic acidBolus (medicine)Internal medicineBiomarkers TumorConfidence IntervalsmedicineHumansInfusions IntravenousAgedbusiness.industryGastroenterologyAntibodies MonoclonalMiddle AgedMETASTATIC COLORECTAL CANCER BEVACIZUMABmedicine.diseaseAntineoplastic Agents PhytogenicSurvival AnalysisBevacizumabIrinotecanRegimenItalyOncologyTolerabilityFluorouracilVitamin B ComplexDisease ProgressionCamptothecinFemaleFluorouracilColorectal NeoplasmsbusinessFebrile neutropeniamedicine.drugClinical Colorectal Cancer
researchProduct

Omalizumab and the risk of malignancy: results from a pooled analysis.

2011

Background Since initial registration, the omalizumab clinical trial database has expanded considerably, with a doubling of patients exposed in the clinical trial environment. Previous pooled data (2003) from phase I to III studies of omalizumab showed a numeric imbalance in malignancies arising in omalizumab recipients (0.5%) compared with control subjects (0.2%). The previous analysis was based on limited available data, warranting further investigation. Objective We sought to examine the incidence of malignancy using comprehensive pooled data from clinical trials of omalizumab-treated patients. Methods This pooled analysis included data from 67 phase I to IV clinical trials. The prespeci…

AdultMaleRiskmedicine.medical_specialtyAdolescentImmunologyOmalizumabOmalizumabRate ratioMalignancyAntibodies Monoclonal HumanizedYoung AdultInternal medicineNeoplasmsImmunology and AllergyMedicineHumansAnti-Asthmatic AgentsYoung adultAdverse effectChildAsthmaAgedAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceAntibodies MonoclonalMiddle Agedmedicine.diseaseSurgeryAntibodies Anti-IdiotypicClinical trialChild PreschoolFemalebusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.

2014

OBJECTIVE: The aim of this study was to evaluate the role of rituximab (RTX) in modulating the expression of the IL-17/IL-23 pathway in the salivary glands (SGs) of patients with primary SS (pSS). METHODS: Consecutive SG biopsies were obtained from 15 patients with pSS before and after 1 year of RTX therapy. The SG expression of IL-17, IL-23p19 and p-STAT3 was evaluated by immunohistochemistry at baseline and after RTX therapy. The role of mast cells in pSS patients in modulating the Th17 response and the immunologic effect of RTX on mast cells were also studied in in vitro experiments. RESULTS: IL-17 was overexpressed in the SGs of patients with pSS mainly by infiltrating T cells and mast …

AdultMaleSTAT3 Transcription FactorSjogren SyndromeApoptosisIn Vitro TechniquesInterleukin-23Peripheral blood mononuclear cellSalivary GlandsAntibodies Monoclonal Murine-DerivedRheumatologystomatognathic systemSettore BIO/13 - Biologia ApplicataBiopsyHumansMedicinePharmacology (medical)Mast CellsAgedmedicine.diagnostic_testbusiness.industryInterleukinsInterleukin-17IL17Middle AgedMast cellIn vitroSettore MED/16 - ReumatologiaSjogren's SyndromeTreatment Outcomemedicine.anatomical_structureApoptosisAntirheumatic AgentsImmunologyTh17 CellsImmunohistochemistryFemaleRituximabInterferonsInterleukin 17businessRituximabSignal Transductionmedicine.drug
researchProduct

vacA genotypes in oral cavity and Helicobacter pylori seropositivity among adults without dyspepsia.

2010

Objective: The aims of this research were to determine the prevalence of Helicobacter pylori and its vacA genotypes in oral cavity in persons without dyspepsia and to establish the association between the presence of H. pylori in oral cavity and oral hygiene. The seroprevalence of anti-H. pylori antibodies and its associated factors were analyzed too. Study design: For the study, 200 adults without dyspepsia symptoms were selected. Dental plaque and saliva samples from each subject were obtained. H. pylori detection in oral samples was carried out by polymerase chain reaction (PCR) and for vacA genotyping a semi-nested and nested PCR was used. The enzyme-linked immunosorbent assay (ELISA) w…

AdultMaleSalivaGenotypeDental plaqueAsymptomaticOral hygieneHelicobacter InfectionsYoung AdultBacterial ProteinsSeroepidemiologic StudiesmedicineSeroprevalenceHumansGeneral DentistryGenotypingMouthbiologyHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationbacterial infections and mycoses:CIENCIAS MÉDICAS [UNESCO]Antibodies BacterialOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASImmunologySurgeryFemalemedicine.symptombusinessNested polymerase chain reactionMedicina oral, patologia oral y cirugia bucal
researchProduct

A 66-kilodalton heat shock protein of Salmonella typhimurium is responsible for binding of the bacterium to intestinal mucus

1992

Salmonella typhimurium infections have increased during the last few years. However, the interplay of virulence factors in S. typhimurium pathogenesis is still poorly understood, particularly with regard to the mechanisms and components of the bacterium which are involved in its interaction with the intestinal mucus. We have observed that S. typhimurium is aggregated by incubation with colonic mucus (guinea pig model). To quantify this phenomenon, an aggregation assay was established. By using this assay, it was found that the aggregation profile of S. typhimurium strains freshly isolated from patients (age 9 and older) with salmonellosis correlated with the severity of the disease. An isol…

AdultMaleSalmonella typhimuriumSalmonellaAdolescentGuinea PigsImmunologyVirulencemedicine.disease_causeMicrobiologyBacterial AdhesionMicrobiologyFecesBacterial ProteinsIntestinal mucosaHeat shock proteinCentrifugation Density GradientmedicineAnimalsHumansIntestinal MucosaChildHeat-Shock ProteinsbiologyTemperatureAntibodies MonoclonalMiddle Agedbiology.organism_classificationEnterobacteriaceaeMucusInfectious DiseasesPolyclonal antibodiesbiology.proteinFemaleParasitologyBacteriaResearch ArticleInfection and Immunity
researchProduct

Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome

2010

AdultMaleSalvage TherapyAdolescentPurpura Thrombotic ThrombocytopenicADAMTS13 ProteinCase ReportMiddle AgedADAM ProteinsAntibodies Monoclonal Murine-DerivedTreatment OutcomeHumansImmunologic FactorsFemaleRituximabrefractory thrombotic thrombocytopenic purpura
researchProduct

Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial.

2005

<i>Background:</i> Patients with chronic urticaria (CU) frequently exhibit positive skin test reactions to autologous serum (ASST). Therapies aimed at inducing tolerance to circulating histamine-releasing factors in ASST+ CU patients, e.g. by treatment with autologous whole blood (AWB), have not yet been tested. <i>Objective:</i> To test whether ASST+ CU patients can benefit from repeated low-dose intramuscular injections of AWB. <i>Methods:</i> We characterized CU severity and duration, anti-Fc<sub>Ε</sub>RI and anti-IgE expression, use of antihistamines, and quality of life in 56 CU patients (ASST+: 35, ASST–: 21) and assessed the t…

AdultMaleSerummedicine.medical_specialtyUrticariaImmunoblottingPlacebo-controlled studyEnzyme-Linked Immunosorbent AssayDermatologymedicine.disease_causePlaceboGastroenterologyAutoimmunityAutohemotherapyBlood Transfusion AutologousInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesChronic urticariaWhole bloodSkin Testsbusiness.industryReceptors IgEImmunoglobulin EMiddle AgedSurgeryAntibodies Anti-IdiotypicClinical trialTreatment OutcomePatient SatisfactionChronic DiseaseQuality of LifeAutologous serum skin testFemalebusinessFollow-Up StudiesDermatology (Basel, Switzerland)
researchProduct

Antibodies for strain 2117-like vesiviruses (caliciviruses) in humans

2015

The vesivirus strain 2117 has been identified as contaminant of bioreactors used for production of human drugs, due to possible contamination of the reagents used for cell cultivation. Using an ELISA assay, antibodies specific for 2117-like viruses were detected in 32/410 (7.8%) human sera, indicating exposure to these viruses.

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaCancer ResearchAdolescentAntibodieCellAntibodies ViralAntibodiesCalicivirusesVesivirus strain 2117Young AdultCaliciviruseSeroepidemiologic StudiesVirologymedicineHumansVesivirusChildVesivirusAgedAged 80 and overbiologyStrain (chemistry)Infant NewbornInfantEnvironmental ExposureElisa assaySeroepidemiologic StudiesEnvironmental exposureMiddle AgedContaminationbiology.organism_classificationVirologyInfectious Diseasesmedicine.anatomical_structureChild Preschoolbiology.proteinFemaleAntibodies; Caliciviruses; Humans; Vesivirus strain 2117AntibodyHumanVirus Research
researchProduct

Relationship between specific serum IGE to Ascaris lumbricoides and onset of respiratory symptoms in Bangladesh immigrants

2006

The role of helminths in asthma and/or rhinitis and in allergic sensitization is still unclear. We assessed the relationship between Ascaris-specific IgE, respiratory symptoms and allergic sensitization in Bangladesh immigrants. 246 individuals were examined from 1996 to 2001. Serum total IgE, Ascaris IgE, specific IgE to inhalant allergens, skin prick tests (SPT) and parasitological evaluation of the stool were performed. Total serum IgE were significantly higher in Ascaris-IgE positive (> 0.35 kU/L) individuals (806.5 [409.0–1436.0] kU/L vs. 207.0 [127.0–332.5] kU/L; P < 0.0001) and in subjects with respiratory symptoms (413.0 [239.0–1096.0] kU/L vs. 259.5 [147.0–387.0] kU/L), ( P …

AdultMaleSettore MED/09 - Medicina InternaRhinitis Allergic Perennial030231 tropical medicineImmunologyAntibodies HelminthImmunoglobulin ESerum ige030308 mycology & parasitologyspecific serum IgEAllergic sensitization03 medical and health sciences0302 clinical medicineAir PollutionImmunology and AllergyMedicineAnimalsHumansRespiratory systemAscaris lumbricoidesAsthmaSkin TestsPharmacology0303 health sciencesFamily Characteristicsbiologybusiness.industryAscarisBangladesh immigrants.specific serum IgE; Ascaris lumbricoides; Bangladesh immigrants.Rhinitis Allergic SeasonalHygieneEmigration and ImmigrationImmunoglobulin Ebiology.organism_classificationmedicine.diseaseAsthmaLogistic ModelsImmunologybiology.proteinAscaris lumbricoideFemaleAntibodyAscaris lumbricoidesbusiness
researchProduct